The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release. – We are ...
American Merck & Co, known in Europe as MSD, has discontinued the development of vibostolimab and favezelimab, two experimental cancer drugs, after their failure in several trials, according to a ...
Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.
Amerikanska Merck & Co, som i Europa är känt som MSD, har beslutat att avbryta utvecklingen av läkemedlen vibostolimab och favezelimab efter flera motgångar, enligt ett pressmeddelande. Dessa ...
– Det känns jättekul och spännande. Jag vill bidra till att vi ser hälso- och sjukvårdssystemet som en helhet och levererar det våra invånare behöver. Det finns mycket spännande i Region Hallands ...
The announcement came after a review that has been ongoing within the European Medicines Agency (EMA) since October last year, and means that its Committee for Medicinal Products for Human Use (CHMP) ...
Tvisten har pågått sedan september 2020 då Sun ansökte till om att få godkännande i USA för att marknadsföra generiska versioner av Zubsolv (buprenorfin och naloxon), som är Orexos ledande produkt för ...
Oskar Hansson, a professor of neurology at Lund University, will hold the title of Vice President for Neurodegenerative Disease Early Phase Clinical and Imaging Development at the American ...
”We should not be the country of moderation. We should compete with the absolute best in the world,” said Minister of Education Johan Pehrson (L) during a press conference on Thursday about the ...
Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development. Therefore, it ...